Cognetivity Neurosciences (CSE: CGN) continues to expand the deployment of its Integrated Cognitive Assessment, or ICA. The firm this morning announced that it has reached a commercial arrangement with the Dubai Health Authority.
The commercial agreement follows a similar deal entered into last month by the company. That transaction saw the firm enter an agreement with the Emirates Health Services, whom is the main federal provider of healthcare within the UAE. The arrangement will see the deployment of the firms ICA across the country.
In terms of the Dubai Health Authority, the commercial agreement will see the firms technology implemented at the busiest dementia clinics within Dubai. The rollout will see the health authority also explore the potential of screening the entire population with the tool as a means of detecting the signs of dementia early in its onset.
The authority is known in the region for being proactive with its healthcare processes, having been one of the first authorities to implement telehealth tech solutions. The offering from Cognetivity will be used by the authority for the early diagnosis of mild cognitive impairment and Alzheimer’s Disease.
“It’s particularly exciting that this project lays the groundwork for even larger, population-wide screening initiatives. With its relatively small size and tech-centred ethos, the UAE is the perfect environment for us to trial such programmes, which we believe we can one day bring to countries as large as the US and China,” stated CEO Sina Habibi on the announcement.
Cognetivity Neurosciences last traded at $0.53 on the CSE.
FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.